Heart FailurePrevalence of Memory Disorders in Ambulatory Patients Aged ≥70 Years With Chronic Heart Failure (from the EFICARE Study)
Section snippets
Methods
EFICARE study is an observational study of ambulatory patients aged ≥70 years with symptomatic HF living in France. Private practice cardiologists were contacted by phone and invited to participate in the study. They were equally distributed by region. To ensure recruitment of a representative population from France as a whole, each cardiologist was asked to recruit the first 4 consecutive patients seen for a routine consultation who met the following criteria: men or women aged ≥70 years, HF
Results
General characteristics of the population (n = 912) at baseline are listed in Table 1. Mean age was 79.1 ± 5.8 years and 590 subjects (65%) were men. Compared with patients with MIS-D[7-8], subjects with MIS-D[0-6] were older, more often women, and had a lower education level. They were also more likely to have renal failure, a history of stroke, depression, and at least 1 fall in the last 12 months and were less likely to be physically active. As expected, level of functional impairment (IADL
Discussion
In this large sample of community-dwelling patients aged ≥70 years with HF, we showed that 46% of patients had memory impairment as identified by MIS-D. In contrast, only 12% of the patients were considered to have memory impairment based on the subjective evaluation by their cardiologists Severity of memory impairment increased with increasing severity of HF. Age, lower education level, low physical activity, depression, history of stroke, and renal failure were independently associated with
Acknowledgment
Data quality control was performed by Axonal S.A., Nanterre, France.
References (30)
- et al.
Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting
Alzheimers Dement
(2013) - et al.
Do general practitioners recognize mild cognitive impairment in their patients?
J Nutr Health Aging
(2010) - et al.
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study
Eur Heart J
(2004) - et al.
Profile of cognitive impairment in chronic heart failure
J Am Geriatr Soc
(2007) - et al.
Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey. On behalf of the GIFA (SIGG-ONLUS) Investigators
J Neurol Neurosurg Psychiatry
(2001) - et al.
Cognitive impairment: a key feature of congestive heart failure in the elderly
J Neurol
(2003) - et al.
Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study
Arch Intern Med
(2006) - et al.
Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease
Cerebrovasc Dis
(2010) - et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur Heart J
(2008) - et al.
Relevance of 10-min delayed recall in dementia screening
Eur J Neurol
(2007)
Four Instrumental Activities of Daily Living Score as a predictor of one-year incident dementia
Age Ageing
Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects
Am J Psychiatry
Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging
Neurology
Prevalence of cognitive impairment in older adults with heart failure
J Am Geriatr Soc
Cited by (32)
Mental involvement in heart failure
2021, Revista Portuguesa de CardiologiaNeurological complications of heart failure
2021, Handbook of Clinical NeurologyCitation Excerpt :Frailty, a syndrome characterized by an exaggerated decline in function and reserve of multiple physiological systems, is common among older patients with HF and is associated with worse outcomes (Pandey et al., 2019). Unfortunately, many HF patients with cognitive impairment are not recognized during their life (Hanon et al., 2014). Cognitive impairment in HF can have a variety of clinical manifestations from mild memory problems through to full dementia.
What is neurogeriatrics?
2020, Revue NeurologiqueCognitive Deficits and Related Brain Lesions in Patients With Chronic Heart Failure
2018, JACC: Heart FailureCitation Excerpt :Interestingly, underperformance in attention tests was strongly associated with severity of HF. In 912 HF outpatients age >70 years, memory impairment (assessed by the delayed-recall Memory Impairment Screen) was present in 46% of subjects and severe memory impairment in 23% (23). In our study, we consistently observed that severity of memory impairment increased with increasing severity of HF.
Self-care confidence may be more important than cognition to influence self-care behaviors in adults with heart failure: Testing a mediation model
2016, International Journal of Nursing StudiesCitation Excerpt :These results have important clinical implications. While several authors recommend routine assessment of cognition in heart failure patient (Alosco et al., 2012; Hanon et al., 2014), our results suggest that routinely assessing self-care confidence may be important as well if we want to improve self-care behaviors. In fact, prior studies (Davis et al., 2012; Flynn et al., 2005; Pozehl et al., 2010; Smeulders et al., 2010) have shown that interventions addressing self-care confidence might be more effective than interventions based on cognitive training to improve self-care behaviors of heart failure patients.
The effect of Mexidol on the improvement of cognitive status and quality of life parameters in the complex therapy of patients with chronic heart failure II-III functional class
2023, Kardiologiya i Serdechno-Sosudistaya Khirurgiya
This study was supported by an unrestricted grant from A. Menarini Industrie Farmaceutiche Riunite Srl, Florence, Italy. Medical writing support was provided by Jenny Grice of inScience Communications, Springer Healthcare. This assistance was funded by A. Menarini Industrie Farmaceutiche Riunite Srl.
See page 1209 for disclosure information.